Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...
Morgan Stanley analyst Bob Huang maintained a Hold rating on Lemonade (LMND – Research Report) today and set a price target of $34.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback